Aytu BioPharma to Present at Upcoming October 2025 Conferences
-
Russia labels 'Mr Nobody Against Putin' teacher a 'foreign agent'
-
Belgian diplomat appeals to avoid trial over Congo leader's murder
-
Whale filmed giving birth, with a little help from her friends
-
France calls Olympic gender test 'a step backwards', other countries approve
-
E-commerce in the crosshairs at WTO in digital taxes battle
-
Volkswagen in talks with defence firms on use of Germany plant: CEO
-
Oil climbs, stocks fall as markets see no end to war
-
Lebanon at real risk of 'humanitarian catastrophe': UN
-
Iran warns civilians as Trump says talks 'going well'
-
Tehran accuses US of 'calculated' assault on school
-
Putin hopes Iran war will shift focus from 'crimes' in Ukraine: German FM
-
Ex-England manager Hodgson, 78, returns as Bristol City boss
-
Police probe firebomb attack on Russian centre in Prague
-
Diamond League athletics meet in Doha still slated for May 8 - organisers
-
Belgium's Goffin to retire at end of season
-
World Cup boost as late goal earns Australia 1-0 win over Cameroon
-
German state railway loss widens, passengers warned of trouble ahead
-
'I'll never be the same': Iranians recount one month of war
-
Back-to-back World Cup titles a 'dream' for Argentina, says Tagliafico
-
Japan to boost coal-fired power as Mideast war causes energy turmoil
-
Mexico searches for missing boats ferrying aid to Cuba
-
G7 allies press Rubio on US Iran plans
-
Iran Guards warn civilians after Trump pushes Hormuz deadline
-
Beached whale frees itself from German coast
-
Global mohair supply flourishes in South Africa's desert
-
Virus kills tiger cubs in Indonesian zoo
-
Indonesian kids brace themselves for social media ban
-
No fans, no fireworks as Pakistan T20 league begins with a hush
-
Piastri outshines Mercedes duo to go fastest in Japan practice
-
New Zealand, Australia say Olympic gender rules bring 'clarity'
-
Gabon battles for baby sea turtles' survival
-
Hungarians' growing anger at living in EU's 'most corrupt state'
-
Mexico's navy says two boats ferrying aid to Cuba are missing
-
Germany eyes Australian 'Ghost Bat' for drone combat era
-
Nepali rapper to be sworn in as new prime minister
-
Cryptocurrencies aiding Iran during war
-
Myanmar travellers ride the rails as fuel prices rise
-
Bolivia, Jamaica close in on World Cup after playoff wins
-
Tech-equipped Indigenous firefighters protect Thai forests
-
Sacred leaf offers hope for Vanuatu's threatened forests
-
Mercedes' Russell fastest in first practice for Japan GP
-
Sabalenka, Sinner keep 'Sunshine Double' in sight with Miami Open wins
-
AI used to make 'fetishised' images of disabled women
-
Oil drops as Trump pauses Iran strikes, but stock traders nervous
-
Parents sacrificed all for 15-year-old India prodigy Suryavanshi
-
Sabalenka subdues Rybakina to reach Miami Open final
-
Newcomers could threaten Christiania's hippie soul, locals fear
-
Hornets sting Knicks to maintain playoff push
-
German 'green village' rides out Mideast energy storm
-
US in the spotlight at WTO meet
Aytu BioPharma to Present at Upcoming October 2025 Conferences
DENVER, CO / ACCESS Newswire / October 10, 2025 / DENVER, CO / ACCESS Newswire / October 10, 2025 /Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced management will participate at the following investor conferences:
2025 Maxim Growth Summit
Date: October 22, 2025
Location: New York City
Investors should reach out to their Maxim sales representatives, or Robert Blum of Lytham Partners at [email protected] to schedule one-on-one meetings with Aytu's management.
Planet MicroCap Showcase: TORONTO 2025
Date: October 22, 2025 - October 23, 2025
Location: Toronto
Presentation Time: 2:30 p.m. Eastern time
Webcast: https://event.summitcast.com/view/34SFNFBix4cZpKNiohrXeh/eV26zB4GZpybjQPU4g6xja
If you would like to schedule one-on-one investor meetings with Aytu's management, and to attend the Planet MicroCap Showcase: TORONTO 2025 in partnership with MicroCapClub, please register here: REGISTER. Conversely, you can contact Robert Blum of Lytham Partners at [email protected] to assist in coordination.
About Aytu BioPharma
Aytu is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. The Company's prescription products include EXXUA™ (gepirone) extended-release tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of major depressive disorder (MDD), Adzenys XR-ODT® (amphetamine) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) and Cotempla XR-ODT® (methylphenidate) extended-release orally disintegrating tablets (see Full Prescribing Information, including Boxed WARNING) for the treatment of attention deficit hyperactivity disorder (ADHD), and a line of legacy products, including Karbinal® ER (carbinoxamine maleate), Poly-Vi-Flor® and Tri-Vi-Flor®. To learn more, please visit aytubio.com.
Contacts for Investors
Ryan Selhorn, Chief Financial Officer
Aytu BioPharma, Inc.
[email protected]
Robert Blum
Lytham Partners
[email protected]
SOURCE: Aytu BioPharma, Inc.
View the original press release on ACCESS Newswire
Ch.Havering--AMWN
